EAN 2019 Archives - Medical Conferences

Home > Neurology > EAN 2019

European Academy of Neurology

29 June – 2 July 2019 Oslo, Norway

Letter from the Editor

Editor

Prof. Hans-Peter Hartung, Heinrich-Heine-University Düsseldorf, Germany

Alzheimer’s Disease and other Dementias

A necessary shift of focus to the earlier stages of Alzheimer’s

Presented By

Prof. Bart de Strooper, Katholieke Universiteit Leuven, Belgium

Biomarkers and how to use them

Antipsychotics increase mortality regardless of comorbidity

Presented By

Dr Ane Nørgaard, Rigshospitalet, Denmark

PDD and DLB represent two different disorders

Epilepsy

Neuroinflammatory pathways as biomarkers and treatment targets

Presented By

Prof. Annamaria Vezzani, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Italy

Panel of inflammation-associated microRNAs as epilepsy biomarker

Clinical and cost effectiveness of levetiracetam vs valproate

Long-term effect of recurrent febrile seizures

Presented By

Dr Julie Werenberg Dreier, Aarhus University, Denmark

Migraine

The role of neurogenic inflammation in migraine

Presented By

Prof. Lars Edvinsson, Lund University, Sweden

Atogepant efficacious, safe, and well-tolerated for migraine prevention

Short- and long-term efficacy of erenumab in hard-to-treat patients

Fremanezumab results of the FOCUS study

Galcanezumab reduces healthcare resource utilisation

Lasmiditan in migraine patients with CV risk factors

Factors influencing choice of prophylactic migraine therapy

Multiple Sclerosis

Treating MS from disease onset

Presented By

Dr Kjell-Morten Myhr, Haukeland University Hospital, Norway

Prognostic blood and MRI biomarkers

Long-term effects of established treatments

Randomised and observational studies comparing treatments

Presented By

Prof. Giancarlo Comi, Vita-Salute San Raffaele University, Italy

Experimental MS treatments

Generalised EBV vaccine for progressive MS well-tolerated

Autologous haematopoietic stem cell transplantation

Presented By

Dr Alice Mariottini, Careggi University Hospital, Italy

Promising results of novel NMOSD treatments

Neuromuscular Disorders

AVXS-101 and nusinersen for spinal muscular atrophy type 1

Ataluren in nonsense mutation Duchenne

Motor nerve biopsy for early diagnosis of lower motor neuron syndromes

Parkinson's Disease and other Movement Disorders

Inflammation may change the course of Parkinson’s disease

Presented By

Prof. Vidar Gundersen, University of Oslo, Norway

No disease-modifying effect of levodopa/carbidopa in Parkinson’s

Novel solution of levodopa/carbidopa prodrugs via CSCI

Opicapone: follow-up on the BIPARK I and II trials

Presented By

Prof. Joaquim J. Ferreira, Laboratorio de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Portugal

Epigallocatechin gallate does not modify MSA progression

Presented By

Dr Johannes Levin, Ludwig-Maximilians-University of Munich, Germany

Stroke

Thrombo-inflammation during ischaemia/reperfusion

Presented By

Prof. Guido Stoll, University of Würzburg, Germany

Table of Contents

Featured articles

Alzheimer’s Disease and other Dementias

Epilepsy

Migraine

Multiple Sclerosis

Neuromuscular Disorders

Parkinson's Disease and other Movement Disorders

Stroke